Quantum Biopharma (NASDAQ:QNTM) Shares Down 4.8% – What’s Next?

Quantum Biopharma Ltd. (NASDAQ:QNTM) was down 4.8% during mid-day trading on Monday . The company traded as low as $4.20 and last traded at $4.40. Approximately 38,219 shares were traded during trading, a decline of 97% from the average daily volume of 1,134,356 shares. The stock had previously closed at $4.62.

Quantum Biopharma Trading Down 1.1 %

The business’s 50-day moving average price is $5.52. The company has a market cap of $8.71 million, a PE ratio of -0.29 and a beta of 0.37.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Quantum Biopharma stock. Virtu Financial LLC acquired a new stake in Quantum Biopharma Ltd. (NASDAQ:QNTM) during the third quarter, according to its most recent filing with the SEC. The firm acquired 11,428 shares of the company’s stock, valued at approximately $46,000. Virtu Financial LLC owned about 0.60% of Quantum Biopharma at the end of the most recent reporting period. 1.24% of the stock is currently owned by institutional investors and hedge funds.

About Quantum Biopharma

Quantum Biopharma Ltd. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company’s three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS.